10/12/2022
FBR, KTBA said that substances registered as drugs under the Drugs Act, 1976 (ie, pharma products) were earlier exempt from the levy of sales tax under the Sales Tax Act, 1990 (“Act”), the Finance (Supplementary) Act, 2022, withdrawn, and the pharma products were made zero-rated in terms of Serial No.19 to the Fifth Schedule of the Act. Later, through the Finance Act 2022, Serial No.19 of the Fifth Schedule was omitted and a new Serial No.81 was introduced in Table 1 of the Eighth Schedule to the Act.